← Leaderboards
Lara Ray
University Of California Los Angeles
$13,872,420
Attributed
$14,835,387
Total exposure
23
Grants
21
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,835,387 · 23
By mechanism
R01$7,567,649 · 4
R21$3,203,574 · 8
N01$1,273,489 · 1
T32$1,235,608 · 1
K24$1,132,940 · 1
R03$317,986 · 3
Top collaborators
- Kate Wassum3 shared
- Mitchell P Karno2 shared
- Amanda K Montoya2 shared
- Erica N Grodin1 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Edythe D London$25,283,467
- Elliot Todd Berkman$9,055,461
- Nicole Petersen$1,379,796
- Gregory V Simpson$10,147,481
- Mark S Cohen$8,053,039
Others in their field
Top investigators on “Alcohols”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$94,107,997
- Willard Cates · Family Health International$73,520,657
- Lloyd D Johnston · University Of Michigan At Ann Arbor$67,097,167
- Elaine D. Eaker · Eaker Epidemiology Enterprises, Llc$63,680,802
- Adolf Pfefferbaum · Sri International$60,705,882
- Richard A Miech · Johns Hopkins University$49,788,168
Research focus
AlcoholsLaboratoriesParticipantPharmaceutical PreparationsSelf AdministrationResponseDrinkingAlcohol CueAlcohol CravingAlcohol ConsumptionCravingAlcohol Use DisorderPlacebosSamplingPharmacotherapyLaboratory StudyAlcohol ResponseResearch PersonnelBaseCuesDoseAddictionPre-ClinicalArea
Grant awards (65)
NEW TASK ORDER AWARD ALCOHOL CUE HUMAN LABORATORY STUDY TESTING APREMILAST. CONTRACTOR TO SERVE AS A CLINICAL RESEARCH SITE FOR A MULTIPLE-SITE CLINICAL TRIAL TO TEST APREMILAST FOR THE TREATMENT OF$579,102
N01 · FY2025 · HD · contact PI
UCLA Training Program in the Translational Neuroscience of Drug Addiction (TNDA)$519,000
T32 · FY2025 · DA
Translational underpinnings of motivation for alcohol in humans$416,531
R01 · FY2025 · AA · contact PI
Clinical Neuroscience of Alcoholism: Integrating Neuroscience and Clinical Trials$213,240
K24 · FY2025 · AA · contact PI
"CORE FUNCTION ACTIVITIES" TASK ORDER TO PROVIDE EXPERT PI PROTOCOL REVIEWS, AD-HOC CONSULTATION, QUERY RESOLUTION AND OVERALL SITE-SPECIFIC MANAGEMENT AND PREPAREDNESS TO CONDUCT NEW STUDIES UNDER TH$11,850
N01 · FY2025 · HD · contact PI
UCLA Training Program in the Translational Neuroscience of Drug Addiction (TNDA)$529,198
T32 · FY2024 · DA
Translational underpinnings of motivation for alcohol in humans$416,531
R01 · FY2024 · AA · contact PI
The effects of stress on decision-making in alcohol use disorder: A translational approach$224,250
R21 · FY2024 · AA · contact PI
Development of Tetrahydrocannabivarin as a Treatment for Smokers$196,875
R21 · FY2024 · DA · contact PI
Translational underpinnings of motivation for alcohol in humans$156,831
R01 · FY2024 · AA · contact PI
Translational Underpinnings of Motivation for Alcohol in Humans$63,714
R01 · FY2024 · AA · contact PI
Translational underpinnings of motivation for alcohol in humans$419,337
R01 · FY2023 · AA · contact PI
ALCOHOL CUE HUMAN LABORATORY STUDY TESTING ASP 8062$282,458
N01 · FY2023 · HD · contact PI
The effects of stress on decision-making in alcohol use disorder: A translational approach$185,250
R21 · FY2023 · AA · contact PI
Integrating findings across stages of medication development for AUD$224,978
R21 · FY2022 · AA · contact PI
UCLA Training Program in the Translational Neuroscience of Drug Abuse (TNDA)$187,410
T32 · FY2022 · DA
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials$183,940
K24 · FY2022 · AA · contact PI
Identifying treatment responders in medication trials for AUD using machine learning approaches$74,776
R03 · FY2022 · AA · contact PI
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder$646,735
R01 · FY2021 · AA · contact PI
NIAAA Medications Development Clinical Investigations Network for the Treatment of Alcohol Use Disorder$400,079
N01 · FY2021 · AA · contact PI
Integrating findings across stages of medication development for AUD$212,801
R21 · FY2021 · AA · contact PI
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials$183,940
K24 · FY2021 · AA · contact PI
A Randomized Controlled Clinical Trial of the Neuroimmune Modulator Ibudilast for the Treatment of Alcohol Use Disorder$154,440
R01 · FY2021 · AA · contact PI
Identifying treatment responders in medication trials for AUD using machine learning approaches$74,776
R03 · FY2021 · AA · contact PI
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder$46,800
R21 · FY2021 · AA · contact PI
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder$662,196
R01 · FY2020 · AA · contact PI
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder$185,250
R21 · FY2020 · AA · contact PI
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials$183,940
K24 · FY2020 · AA · contact PI
A NOVEL HUMAN LABORATORY MODEL FOR SCREENING MEDICATIONS FOR ALCOHOL USE DISORDER$83,641
R21 · FY2020 · AA · contact PI
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder$627,547
R01 · FY2019 · AA · contact PI
A Novel Human Laboratory Model for Screening Medications for Alcohol Use Disorder$224,250
R21 · FY2019 · AA · contact PI
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials$183,940
K24 · FY2019 · AA · contact PI
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder$30,057
R01 · FY2019 · AA · contact PI
A randomized controlled clinical trial of the neuroimmune modulator ibudilast for the treatment of alcohol use disorder$608,362
R01 · FY2018 · AA · contact PI
Clinical neuroscience of alcoholism: integrating neuroscience and clinical trials$183,940
K24 · FY2018 · AA · contact PI
Combining varenicline and naltrexone for smoking cessation and drinking reduction$672,621
R01 · FY2017 · DA · contact PI
Combining varenicline and naltrexone for smoking cessation and drinking reduction$663,608
R01 · FY2016 · DA · contact PI
Perceived alcohol reward value and risk: Neural correlates and treatment effects$152,917
R21 · FY2016 · AA
Combining Varenicline and Naltrexone for Smoking Cessation in Heavy Drinkers$99,766
R01 · FY2016 · DA · contact PI
Combining varenicline and naltrexone for smoking cessation and drinking reduction$672,621
R01 · FY2015 · DA · contact PI
Optimizing naltrexone for individuals of East Asian descent$384,658
R01 · FY2015 · AA · contact PI
Perceived alcohol reward value and risk: Neural correlates and treatment effects$190,982
R21 · FY2015 · AA
Modeling alcohol reward and reinforcement in the human laboratory$177,388
R21 · FY2015 · AA · contact PI
Optimizing Naltrexone for Individuals of East Asian Descent$70,589
R01 · FY2015 · AA · contact PI
Optimizing naltrexone for individuals of East Asian descent$384,131
R01 · FY2014 · AA · contact PI
Modeling alcohol reward and reinforcement in the human laboratory$221,375
R21 · FY2014 · AA · contact PI
Development of Ibudilast as a Novel Treatment for Alcoholism$177,388
R21 · FY2014 · AA · contact PI
Optimizing naltrexone for individuals of East Asian descent$417,374
R01 · FY2013 · AA · contact PI
Development of Ibudilast as a Novel Treatment for Alcoholism$221,375
R21 · FY2013 · AA · contact PI
Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder$25,196
R21 · FY2013 · DA · contact PI
Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder$192,500
R21 · FY2012 · DA · contact PI
Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder$29,358
R21 · FY2012 · DA · contact PI
Pharmacogenetics of Natlrexone for Methamphetamine Use Disorder$231,000
R21 · FY2011 · DA · contact PI
Neuroimaging probes of medication response in smokers$37,345
R03 · FY2011 · DA · contact PI
Neuroimaging probes of medication response in smokers$15,974
R03 · FY2011 · DA · contact PI
Neuroimaging probes of medication response in smokers$38,500
R03 · FY2010 · DA · contact PI
Integrating Laboratory Neuroimaging Phenotypes$38,115
R03 · FY2010 · AA · contact PI
IV ALCOHOL ADMINISTRATION AND ALCOHOL CUES$18,458
M01 · FY2010 · RR · contact PI
PHARMACOGENETICS OF NALTREXONE IN ASIAN AMERICANS$3,955
M01 · FY2010 · RR · contact PI
PHARMACOLOGICAL INTERVENTION FOR HEAVY-DRINKING SMOKERS$1,319
M01 · FY2010 · RR · contact PI
MECHANISMS OF QUETIAPINE FOR ALCOHOL DEPENDENCE$659
M01 · FY2010 · RR · contact PI
Integrating Laboratory Neuroimaging Phenotypes$38,500
R03 · FY2009 · AA · contact PI
Genetic Correlates of Alcohol Use Disorders$23,522
F31 · FY2006 · AA · contact PI
Genetic Correlates of Alcohol Use Disorders$28,114
F31 · FY2005 · AA
Genetic Correlates of Alcohol Use Disorders$28,114
F31 · FY2004 · AA